HanchorBio Inc. 漢康生技股份有限公司
Yuehua Cong currently serves as the Chief Business Officer and Senior Vice President at HanchorBio Inc. since October 2023. Previously, Yuehua was the Founding Director at Simcere UK Ltd from December 2017 to October 2023 and held the position of Executive Director at Simcere Pharmaceutical Group, where responsibilities included establishing the company's presence in Europe and managing business development activities. Prior experiences include a role as Executive Director of Business Development at F-star Biotechnology Ltd from February 2013 to September 2017 and various positions at PolyTherics Ltd, including Scientific Liaison for China and research roles. Yuehua's academic background includes a PhD from the University of Konstanz and master's degrees in quality safety environment and polymer science from Otto-von-Guericke University Magdeburg and Northeastern University, respectively.
This person is not in any teams
This person is not in any offices
HanchorBio Inc. 漢康生技股份有限公司
HanchorBio (漢康生技) is developing a technology for the creation of next generation personalized biotherapeutics. Based in San Francisco, Taipei, and Shanghai, we are led by a group of pharmaceutical industry veterans with proven track-record of success is biologics discovery and global development with bold vision to rewrite immunotherapies. Committed to reactivating the immune system to fight against diseases, our proprietary Fc-based designer biologics (FBDB™) platform enables unique biologics with diverse multi-targeting modalities to unleash both innate and adaptive immunity to help revolutionize the treatment of people with cancer and other debilitating diseases. Our FBDB™ platform has successfully delivered proof-of-concept data in several in-vivo animal models. By making breakthroughs in multi-functional innovative molecular configurations in R&D and improving the manufacturing methodology in CMC, we develop transformative medicines to address unmet medical needs.